Roche gets accelerated U.S. approval for lung cancer drug

(Reuters) - U.S. health regulators on Friday said they have granted accelerated approval to Roche Holding's drug for advanced lung cancer in patients with a specific genetic mutation.

http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro